Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06960980 · ClinicalTrials.gov registry record · NA

Improving ADHD Teen Driving - Virtual Reality

A NA study of Attention Deficit Hyperactivity Disorder (ADHD), sponsored by Children's Hospital Medical Center, Cincinnati.

Recruiting
Registry status
NA
Development phase
204
Enrollment target
1
Study location

NCT06960980: Recruiting NA study of Attention Deficit Hyperactivity Disorder (ADHD), sponsored by Children's Hospital Medical Center, Cincinnati.

NCT06960980 is a NA study of Attention Deficit Hyperactivity Disorder (ADHD) that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 204 participants, above the 130-participant average among 18 other Attention Deficit Hyperactivity Disorder (ADHD) trials with a reported enrollment target (57% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06960980, a NA study of Attention Deficit Hyperactivity Disorder (ADHD), is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.

RECRUITING
Registry status
NA
Development phase
204 participants
Enrollment target
1
Study location

Study Summary

Teens with Attention-Deficit/Hyperactivity Disorder (ADHD) have high rates of negative driving outcomes, including motor vehicle crashes, which may be caused by visual inattention (i.e., looking away from the roadway to perform secondary tasks). Two versions of a driving intervention that trains teens to reduce instances of looking away from the roadway will be tested in teens with ADHD.

Primary Outcome

Participants will complete a simulated drive in a driving simulator with an integrated eye-tracking system. Participants will complete two 15-minute drives. During each drive, participants will engage in 14 secondary tasks. The secondary task consist of searching for streets on a GPS map for 20 seconds. Eye gaze will be sampled continuously. Eye gaze data will be summarized by calculating the number of extended (≥2 secs) glances away from the roadway during the 14 secondary task periods per driv

Interventions

  • BEHAVIORAL FOCAL+
  • BEHAVIORAL VR-FOCAL+

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2025-09-11
Est. Completion 2029-08-31
Phase NA

What NCT06960980 shows while recruiting

NCT06960980 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, above the 130-participant average among 18 other Attention Deficit Hyperactivity Disorder (ADHD) trials with a reported enrollment target (57% higher).

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder (ADHD) appearing as the primary indexed condition, and to 2 interventions - of which FOCAL+ is the first listed.

NCT06960980 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06960980 about?

NCT06960980 is a clinical study titled "Improving ADHD Teen Driving - Virtual Reality". Teens with Attention-Deficit/Hyperactivity Disorder (ADHD) have high rates of negative driving outcomes, including motor vehicle crashes, which may be caused by visual inattention (i.e., looking away from the roadway to perform secondary tasks). Two versions of a driving intervention that trains tee...

What is the current status of trial NCT06960980?

This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2025-09-11. Estimated completion is 2029-08-31.

What conditions does trial NCT06960980 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder (ADHD).

What interventions are being tested in trial NCT06960980?

The interventions under investigation include: FOCAL+ (BEHAVIORAL), VR-FOCAL+ (BEHAVIORAL).

Who is sponsoring clinical trial NCT06960980?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06960980 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention Deficit Hyperactivity Disorder (ADHD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06960980's enrollment target sits among peer trials

204 5th of 18 higher than 14 of 18 other Attention Deficit Hyperactivity Disorder (ADHD) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder (ADHD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

  • NCT04249830 · 204 participants · NA

    Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults

  • NCT04503395 · 204 participants · NA

    ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

  • NCT04793776 · 204 participants · NA

    Manage Emotions to Reduce Aggression (MERA)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06960980, the US trial registry maintained by the National Library of Medicine. NCT06960980 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.